Andrin Oswald is the founder of Centogene. Latest round: Series A. Backed by Vi Partners. Based in Rostock, Germany.
Andrin Oswald was named CEO of Centogene, a German rare disease biotech, in October 2020, succeeding Arndt Rolfs. Centogene focuses on rare disease diagnostics and research. In October 2024, Somagenetix AG, a biotech company pioneering gene therapy for phagocyte disorders, announced the initial closing of its CHF 10 million Series A financing round.
Full founder directory · Investor directory · Company funding database · Fundraising library